Net Profit Compound Annual Growth Rate (CAGR) is a financial metric that measures the mean annual growth rate of a company’s net profit over a specific period of time, assuming the profits grow at a steady rate each year.
Unlike simple average growth rates, CAGR smooths out volatility to provide a clearer picture of long-term profitability trends. This metric is particularly useful for investors and analysts to assess a company’s financial performance, compare profitability across peers, and evaluate management effectiveness in generating consistent profit growth over time.
Following are three stocks held by Ashish Kacholia with a 3-year net profit CAGR of more than 20 percent, as of FY25:
Tanfac Industries Limited
With a market cap of Rs. 3,000.4 crores, the shares of one of India’s leading players in Fluorine Chemicals moved up by nearly 2 percent on BSE to hit an intraday high at Rs. 3,059.95 on Friday.
The net profit of Tanfac Industries increased by a CAGR of nearly 16 percent to Rs. 88 crores in FY25, as compared to Rs. 56 crores in FY23. As of the March 2025 shareholding pattern with the BSE, ace investor Ashish Kacholia holds a 1.59 percent stake in the company.
Tanfac Industries Limited, a joint venture between Anupam Rasayan India Limited and the Tamil Nadu Industrial Development Corporation (TIDCO), is a key player in the production of hydrofluoric acid and its derivatives, including aluminium fluoride and specialty chemicals.
Aeroflex Industries Limited
With a market cap of Rs. 2,047 crores, the stock moved up by nearly 1 percent on BSE to hit an intraday high at Rs. 158.55 on Friday. The net profit of Aeroflex Industries increased by a CAGR of nearly 21 percent to Rs. 53 crores in FY25, as compared to Rs. 30 crores in FY23.
As of the March 2025 shareholding pattern with the BSE, the ace investor Ashish Kacholia holds a 1.92 percent stake in the company (under his name). Aeroflex Industries Limited is engaged in the business of manufacturing stainless steel flexible hose with braiding and without braiding, and assemblies.
Ami Organics Limited
With a market cap of Rs. 9,497.2 crores, shares of a leading global manufacturer of advanced pharmaceutical intermediates and speciality chemicals moved up by nearly 0.1 percent on BSE to hit an intraday high at Rs. 1,164.05 on Friday. The net profit of Ami Organics increased by a CAGR of nearly 24 percent to Rs. 160 crores in FY25, as compared to Rs. 83 crores in FY23. As of the March 2025 shareholding pattern with the BSE, the ace investor Ashish Kacholia holds a 1.72 percent stake in the company.
Ami Organics Limited is engaged in the development and manufacturing of advanced pharmaceutical intermediates for regulated and generic active pharmaceutical ingredients (APIs) and chemicals for New Chemical Entities (NCE), and other specialty chemicals including parabens, semiconductor chemicals, electrolyte additives and niche key starting materials for cosmetics, fine chemicals and agrochemical industries.
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
